In the context of the 78th World Health Assembly (WHA) being held in Geneva on 19–27 May 2025, the European Brain Council (EBC) fully supports the Resolution on Rare Diseases: ‘Rare Diseases: A Global Health Priority for Equity and Inclusion’. Spearheaded by Rare Diseases International and a broad coalition of partners, this initiative acknowledges [...]
As this week marks the 2025 edition of the European Mental Health Awareness Week, EBC is pleased to note the increasing momentum behind mental health at both the European and global levels. However, despite recent progresses in developing and enlarging mental health policies, much remains to be done to ensure that the needs of [...]
The European Union research and innovation ecosystem is at a turning point. While the Letta, Draghi & Heitor reports emphasised the instrumental role played by research and innovation in driving forward Europe’s leadership in life sciences and its overall competitiveness, challenges are mounting including strained budgets, a strongly competitive funding environment, increasing bureaucratic burdens [...]
On March 11, the European Commission presented the much-anticipated Critical Medicines Act, a proposal aimed at strengthening the resilience and autonomy of the EU’s pharmaceutical supply chain. The European Brain Council (EBC) welcomes this initiative as an important step toward a stronger, more innovative, and competitive Health Union, particularly in light of increased geopolitical [...]
